ArticleCancers2026

Real-World Dermatologic Adverse Events of CAR T-Cell Therapy: A Decade-Wide Disproportionality Analysis of the FDA Adverse Event Reporting System.

Manideepa Maji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.